Stockreport

Akari Therapeutics receives $30M capital commitment [Seeking Alpha]

Akari Therapeutics Plc - American Depositary Shares  (AKTX) 
US:NASDAQ Investor Relations: investor.akaritx.com/investor-relations
PDF Akari Therapeutics (AKTX+7.6%$30M in the securities purchase commitmentsuccess of phase IIThe facility adds to its initial $20M deal with Aspire, one of its largest shar [Read more]